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Background: There have been few studies that comparing the efficacy and safety of bare-metal stents (BMS) versus second-generation drug-
eluting stents (DES) in patients with acute myocardial infarction (AMI).
methods: We analyzed consecutive 1,267 AMI patients underwent percutaneous coronary intervention (PCI) using BMS or 2nd generation DES in 
COREA-AMI (COnvergent REgistry of cAtholic and chonnAm university for AMI) enrolled from January 2004 to December 2009. We compared cardiac 
death, non-fatal myocardial infarction (MI), and target lesion revascularization (TLR) and target lesion failure (TLF) including cardiac death, non-fatal 
MI or TLR according to stent type.
results: Median follow up duration was 29 months (interquatile range 21 - 40). A total of 384 patients and 883 patients were treated with BMS 
and 2nd generation DES, respectively. The rate of cardiac death, non-fatal MI, target lesion revascularization and TLF was higher in BMS (18.5 
% vs. 8.4 %, p<0.001, 3.4 % vs. 1.2 %, p=0.01, 11.2 % vs. 4.2 %, p<0.001, 30.3 % vs. 13.8%, p<0.001, respectively). Furthermore, the using of 
2nd generation DES reduced independently TLF (hazard ratio 0.642, 95 % confidence interval 0.481-0.857, p=0.003) in multivariate Cox hazard 
regression model (table 1).
conclusions: In patients with acute myocardial infarction, treatment with second-generation DES is associated with decreased TLF as compared 
with treatment with BMS.
 
